Baylosis, Jona .

HRN: 23-20-47  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2023
CEFUROXIME 1.5GM (VIAL)
06/24/2023
06/24/2023
IV
1.5 G
Prior To OR
Elective Primary CS
Waiting Final Action 
06/24/2023
CEFUROXIME 1.5GM (VIAL)
06/24/2023
06/25/2023
IV
500mg
Q8 X 3 Doses
S/P Primary LTCS
Waiting Final Action 
06/24/2023
CEFUROXIME 500MG (TAB)
06/25/2023
07/02/2023
PO
500mg
BID X 7 Days
S/P Primary LTCS
Waiting Final Action 
06/24/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/24/2023
06/25/2023
IV
500mg
Q8 X 3 Doses
S/P Primary LTCS
Waiting Final Action 
06/24/2023
METRONIDAZOLE 500MG (TAB)
06/25/2023
07/02/2023
PO
500mg
TID X 7 Days
S/P Primary LTCS
Waiting Final Action 
06/25/2023
CEFUROXIME 500MG (TAB)
06/25/2023
07/02/2023
PO
500
Bid
Lrcs
Waiting Final Action 
06/25/2023
METRONIDAZOLE 500MG (TAB)
06/25/2023
07/02/2023
PO
500
Tid
Ltcs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: